The presence of EZH2 mutations is indicative of more progressive disease as highlighted above in myelofibrosis and by Lasho and McNamara in leukemic transformation with 15% and 7% identified in each cohort respectively [61,62]. The gene discussed is EZH2; the disease is myelofibrosis.